(Q36008285)

English

Receptor-mediated tumor targeting with radiopeptides. Part 1. General concepts and methods: applications to somatostatin receptor-expressing tumors

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

Receptor-mediated tumor targeting with radiopeptides. Part 1. General concepts and methods: applications to somatostatin receptor-expressing tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

author name string

Alex N Eberle

1

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Gabriele Mild

2

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Sylvie Froidevaux

3

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Journal of Receptors and Signal Transduction

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

319-455

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Radiotoxicity of iodine-125 and other auger-electron-emitting radionuclides: background to therapy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Significance of (111)In-DTPA chelate in renal radioactivity levels of (111)In-DTPA-conjugated peptides.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Distribution, ontogeny and ultrastructure of somatostatin immunoreactive cells in the pancreas and gut

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Expression of somatostatin receptors in uveal melanomas

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Nephrotoxicity versus anti-tumour efficacy in radiopeptide therapy: facts and myths about the Scylla and Charybdis

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Intraoperative tumour detection using 111In-DTPA-D-Phe1-octreotide and a scintillation detector

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor imaging in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Biokinetics of 111In-DTPA-D-Phe(1)-octreotide in nude mice transplanted with a human carcinoid tumor

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Biodistribution of 111in-DTPA-D-Phe1-octreotide in tumor-bearing nude mice: influence of amount injected and route of administration

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Technetium labeled small peptide radiopharmaceuticals in the identification of lung cancer

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Facts and myths about radiopeptide therapy: Scylla, Charybdis and Sibyl

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Radionuclide therapy with iodine-125 and other auger-electron-emitting radionuclides: experimental models and clinical applications

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Antiproliferative effect of somatostatin and analogs

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Anti-tumor effect and increased survival after treatment with [177Lu-DOTA0,Tyr3]octreotate in a rat liver micrometastases model

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Binding properties of somatostatin receptor subtypes

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Imaging and therapy of tumors induced to express somatostatin receptor by gene transfer using radiolabeled peptides and single chain antibody constructs

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Assessment of hepatic toxicity from treatment with 90Y-SMT 487 (OctreoTher(TM)) in patients with diffuse somatostatin receptor positive liver metastases

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

99mTc-depreotide tumour uptake in patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Tumour therapy with radionuclides: assessment of progress and problems.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Breast cancer staging using technetium-99m sestamibi and indium-111 pentetreotide single-photon emission tomography.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Diagnosis and staging of children's lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Octreotide scanning for carcinoid tumours

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Current and potential therapeutic uses of lanthanide radioisotopes

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

End-stage renal disease after treatment with 90Y-DOTATOC.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

A physiologic role for somatostatin 28 as a regulator of insulin secretion

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Imaging of pituitary tumours.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Peptide receptor radiotherapy: a new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma Group

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

99mTc-Demotate 1: first data in tumour patients-results of a pilot/phase I study

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

BLEDTA: tumor localization by a bleomycin analog containing a metal-chelating group

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Technetium-99m labelling of glycosylated somatostatin-14.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Radiolabeled α‐melanocyte‐stimulating hormone analogs for receptor‐mediated targeting of melanoma: from tritium to indium

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

[111In-DPTA-D-Phe1]-octreotide scintigraphy in the management of patients with advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Optimization of the small-scale synthesis of DOTA-Tyr3 -octreotide

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor scintigraphy for bronchial carcinoid follow-up

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Malignancy in slow motion: diagnosis of biochemically apparent, but otherwise occult persistent disease 21 years after resection of a carcinoid tumour of the terminal ileum

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin analogs and radiopeptides in cancer therapy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

A microplate binding assay for the somatostatin type-2 receptor (SSTR2).

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

99mTc-N4-[Tyr3]Octreotate Versus 99mTc-EDDA/HYNIC-[Tyr3]Octreotide: an intrapatient comparison of two novel Technetium-99m labeled tracers for somatostatin receptor scintigraphy.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

99mTc-EDDA/HYNIC-TOC and (18)F-FDG in thyroid cancer patients with negative (131)I whole-body scans.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Direct labelling of octreotide with 99mTc: effect of different concentration of reducing agents and amount of sodium pertechnetate on radiolabelling efficiency

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Octreotide-scintigraphy is a disease-activity parameter in Graves' ophthalmopathy.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin: the neuroendocrine story

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Role of nuclear medicine in the evaluation of the solitary pulmonary nodule

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin-receptor imaging in lymphoma

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Radionuclide-labeled somatostatin analogues for diagnostic and therapeutic purposes in nonmedullary thyroid cancer

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Imaging lung tumors with peptide-based radioligands

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Cloning of the gene encoding human somatostatin receptor 2: sequence analysis of the 5'-flanking promoter region

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor targeting for tumor imaging and therapy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with (111)In-DTPA-JIC 2DL.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Differential expression of somatostatin receptors in medulloblastoma

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Monoclonal antibodies as therapeutic agents for cancer

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

111In-labelled octreotide binding by the somatostatin receptor subtype 2 in neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Comparison of tc-99m depreotide and in-111 octreotide in recurrent meningioma

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Receptor targeting for tumor localisation and therapy with radiopeptides

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

In-111 octreotide imaging in staging of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

The pathophysiological consequences of somatostatin receptor internalization and resistance

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Localization of small-cell lung cancer xenografts with iodine-125-, indium-111-, and rhenium-188-somatostatin analogs.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Role of (111)In-DTPA-pentetreotide scintigraphy in accurate diagnosis of neuroendocrine gastroenteropancreatic tumors

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

[111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Expression of somatostatin receptor subtypes and growth inhibition in human exocrine pancreatic cancers.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

17 beta-estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Expression cloning of a rat brain somatostatin receptor cDNA

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptors in Neuro2A neuroblastoma cells: ligand internalization

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Gastric carcinoid with histamine production, histamine transporter and expression of somatostatin receptors

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Is the Renal Dosimetry for [90Y-DOTA0, Tyr3]Octreotide Accurate Enough to Predict Thresholds for Individual Patients?

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Evaluation of Positron Emission Tomography Imaging Using [68Ga]-DOTA-D Phe1-Tyr3-Octreotide in Comparison to [111In]-DTPAOC SPECT. First Results in Patients with Neuroendocrine Tumors

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin analogues in the treatment of thyroid eye disease

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

The role of octreoscan in thyroid eye disease

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Lanreotide in the treatment of patients with thyroid eye disease.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

111In-octreotide scintigraphy in oncology

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Radiation doses deriving from patients undergoing 111In-DTPA-D-phe-1-octreotide scintigraphy.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor scintigraphy in patients with carcinoid tumors

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Radiolabeled somatostatin analog scintigraphy in oncology and immune diseases: an overview

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor imaging

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

The visualization of gastroenteropancreatic endocrine tumors

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor imaging in the diagnosis and treatment of neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Peptides as carrier for tumor diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Functional imaging of Langerhans cell histiocytosis by (111)In-DTPA-D-Phe(1)-octreotide scintigraphy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Octreotide and octreotate derivatives radiolabeled with yttrium: pharmacokinetics in rats

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Distribution and elimination characteristics of 111In-DTPA-D-phe1-octreotide and 111In-DTPA-L-phe1-octreotide in rats

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Antiproliferative activity induced by the somatostatin analogue, TT-232, in human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Beta2-amino acids-syntheses, occurrence in natural products, and components of beta-peptides1,2.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Toxicity and dosimetry of (177)Lu-DOTA-Y3-octreotate in a rat model.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Distribution and functional significance of somatostatin receptors in malignant melanoma.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

111Indium (DTPA-octreotide) scintigraphy in patients with cerebral gliomas

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

[99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technetium-99m

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Molecular imaging in living subjects: seeing fundamental biological processes in a new light

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Ectopic Cushing's syndrome and pulmonary carcinoid tumour identified by [111In-DTPA-D-Phe1]octreotide

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Successful targeted radiotherapy with 90Y-DOTATOC in a patient with Merkel cell carcinoma. A Case Report

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

99mTc-depreotide scintigraphy of bone lesions in patients with lung cancer.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

68Ga-labelled DOTA-derivatised peptide ligands

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Use of an isotopic somatostatin receptor probe to image gut endocrine tumors

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Cloning of the mouse SSTR5 gene

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

A possible role for somatostatin receptor scintigraphy in the diagnosis and follow-up of children with medulloblastoma

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin Receptor Subtypes in Human Pheochromocytoma: Subcellular Expression Pattern and Functional Relevance for Octreotide Scintigraphy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

GOT1 xenografted to nude mice: a unique model for in vivo studies on SSTR-mediated radiation therapy of carcinoid tumors

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan).

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Cerebral deafferentiation in operated gliomas as a predictor for malignancy?

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Diagnostic localization of pheochromocytoma: the coming of age of positron emission tomography

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin and its receptor family

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Molecular biology of somatostatin receptor subtypes

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5).

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Technetium-99m direct radiolabeling of lanreotide: a somatostatin analog

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Enzymatic cleavage of peptide-linked radiolabels from immunoconjugates.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N', N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Protein tyrosine nitration in cytokine-activated murine macrophages. Involvement of a peroxidase/nitrite pathway rather than peroxynitrite

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Expression of somatostatin type 2A receptor correlates with estrogen receptor in human breast carcinoma.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Clinical usefulness of 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: a pilot study

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

99mTc-EDDA/HYNIC-TOC scintigraphy in the differential diagnosis of solitary pulmonary nodules.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Clinical usefulness of 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: a preliminary communication.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Octreotide scans are positive in a subset of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Polymethylated DOTA ligands. 1. Synthesis of rigidified ligands and studies on the effects of alkyl substitution on acid-base properties and conformational mobility

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Polymethylated DOTA ligands. 2. Synthesis of rigidified lanthanide chelates and studies on the effect of alkyl substitution on conformational mobility and relaxivity

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Large-scale synthesis of the bifunctional chelating agent 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetr aacetic acid, and the determination of its enantiomeric purity by chiral chromatography

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Receptor imaging of human diseases using radiolabeled peptides

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Biodistribution of [111In-DTPA-d-Phe1]-octreotide in dogs: uptake in the stomach and intestines but not in the spleen points towards interspecies differences

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Cloning and characterization of a fourth human somatostatin receptor

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Identification and characterization of subtype selective somatostatin receptor agonists

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-DPhe1- Tyr3-octreotide ([86Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90Y-labelled analogue.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Endocytosis of the rat somatostatin receptors: subtype discrimination, ligand specificity, and delineation of carboxy-terminal positive and negative sequence motifs

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Functional scintigraphy of the adrenal gland

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Antibodies and gene therapy: teaching old 'magic bullets' new tricks

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Multiple endocrine neoplastic-associated thymic carcinoid tumour in close relatives: octreotide scan as a new diagnostic and follow-up modality. Two case reports.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Molecular cloning and functional characterization of a rat somatostatin sst2(b) receptor splice variant

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor imaging in intracranial tumours

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Biodistribution and dosimetry of 177Lu-labeled [DOTA0,Tyr3]octreotate in male nude mice with human small cell lung cancer

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydrates

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

True positive somatostatin receptor scintigraphy in primary breast cancer correlates with expression of sst2A and sst5.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Tc-99m depreotide detecting malignant pulmonary nodules: histopathologic correlation with semiquantitative tumor-to-normal lung ratio

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

[125I]Tyr10-cortistatin14 labels all five somatostatin receptors

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Indium-111-octreotide scintigraphy, intraoperative gamma-detector localisation and somatostatin receptor expression in primary human breast cancer.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Synthesis and characterisation of [90Y]-Bz-DTPA-oct: a yttrium-90-labelled octreotide analogue for radiotherapy of somatostatin receptor-positive tumours

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Intensification of 111In-DTPA-octreotide scintigraphy by means of pretreatment with cold octreotide in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Six month follow-up after 111In-DTPA-octreotide therapy in patients with progressive radioiodine non-responsive thyroid cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-DPhe1, Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Distribution of somatostatin receptors in RINm5F insulinoma cells

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Tissue distribution of octreotide binding receptors in normal mice and strains prone to autoimmunity

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3]octreotate

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

The diagnostic utility of somatostatin receptor scintigraphy in oncology

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Peptide receptor imaging: advances in the diagnosis of pulmonary diseases

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor imaging and therapy of pancreatic endocrine tumors

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin-receptor scintigraphy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Radionuclide tumour therapy with ultrasound contrast microbubbles.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Cloning and expression of a novel mouse somatostatin receptor (SSTR2B).

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 gene

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Dexamethasone effects on somatostatin receptors in pancreatic acinar AR4-2J cells

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Mack Forster Award Lecture. Receptor nuclear medicine: vasointestinal peptide and somatostatin receptor scintigraphy for diagnosis and treatment of tumour patients

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor subtype expression in human tissues: a prediction for diagnosis and treatment of cancer?

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Experience with indium-111 and yttrium-90-labeled somatostatin analogs

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Radiopeptide transmitted internal irradiation of non-iodophil thyroid cancer and conventionally untreatable medullary thyroid cancer using

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Opportunities in somatostatin research: biological, chemical and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin analogs for diagnosis and treatment of cancer

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Radiolabeled peptides in the diagnosis and therapy of oncological diseases

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration on the pharmacokinetics

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

The outstanding metabolic stability of a 14C-labeled beta-nonapeptide in rats--in vitro and in vivo pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Molecular cloning and sequencing of a human somatostatin receptor, hSSTR4

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Radioisotope-guided surgery in patients with neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Internalisation of isotope-coupled somatostatin analogues

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor manipulation

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Gallbladder visualization with In-111 labeled octreotide.

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

In vitro and in vivo studies of three radiolabelled somatostatin analogues:123I-Octreotide (OCT),123I-Tyr-3-OCT and111In-TIRA-d-Phe-1-OCT

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Somatostatin receptor (SSTR) scintigraphy in patients with osteosarcoma

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Tc-99m Sestamibi and In-111 DTPA Octreotide Uptake in Breast Carcinoma With Neurendocrine Differentiation

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumours and evaluation of intraoperative scintillation detection

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Polyaminopolycarboxylic Acids derived from Polyethyleneamines

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

A potent cyclic hexapeptide analogue of somatostatin

1 reference

https://api.crossref.org/works/10.1081%2FRRS-200040939

21 January 2018

Identifiers

10.1081/RRS-200040939

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36008285&oldid=1979843205"